CSIMarket
Company Name or Ticker Symbol
Search for other Categories


Enanta Pharmaceuticals Inc  (ENTA)
Other Ticker:  
 


 

Enanta Pharmaceuticals Inc

ENTA's Financial Statements and Analysis



Enanta Pharmaceuticals Inc reported in I. Quarter net earnings per share of $1.25 an increase by 111.86 % year on year from $0.59 and decline of -3.98 % from $1.30 earned in IV. Quarter (Sep 30 2018).


I. Quarter
Earnings Per Share Revenues
$ 1.25 $  70 Mill
$+0.66     +111.86 % $+32M     +83.38 %



Enanta Pharmaceuticals Inc's Revenue rose by 83.38 % in I. Quarter (Dec 31 2018) year on year, to $70 million and advanced by sequentially.


Enanta Pharmaceuticals Inc is

More on ENTA's Income Statement



Enanta Pharmaceuticals Inc's net income of $26 million in I. Quarter increased by 122.45 % from net earnings of $12 million achieved in I. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-44.54 million recorded in previous quarter.

More on ENTA's Growth

In I. Quarter company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -23.81%, to $-0 millions compare to same quarter a year ago and rose by -38.36% from IV. Quarter (Sep 30 2018).

More on ENTA's Cash flow Statement


Enanta Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Enanta Pharmaceuticals Inc earned $ 2.65 cash per share, on a free-cash flow basis 64.07 % of net earning per share.

Book value grew by 9.75 % sequentially to $20.51 per share, 110.53% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 20.51 per share from $ 18.69.

Company repurchased 0.25 million shares or 1.21 % in I. Quarter.
Interest Coverage Ratio was 16.98.

More on ENTA's Dividends

 Market Capitalization (Millions) 1,985
 Shares Outstanding (Millions) 21
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 32
 Net Income (TTM) (Millions $) 14
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) -3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Enanta Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Enanta Pharmaceuticals Inc earned $ 2.65 cash per share, on a free-cash flow basis 64.07 % of net earning per share.

Book value grew by 9.75 % sequentially to $20.51 per share, 110.53% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 20.51 per share from $ 18.69.

Company repurchased 0.25 million shares or 1.21 % in I. Quarter.
Interest Coverage Ratio was 16.98.

More on ENTA's Balance Sheets

 Market Capitalization (Millions) 1,985
 Shares Outstanding (Millions) 21
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 32
 Net Income (TTM) (Millions $) 14
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) -3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SINT's Profile

Stock Price

SINT's Financials

Business Description

Fundamentals

Charts & Quotes

SINT's News

Suppliers

SINT's Competitors

Customers & Markets

Economic Indicators

SINT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071